Skip to main content
. 2017 Apr 21;8(24):39198–39208. doi: 10.18632/oncotarget.17338

Table 7. Stratified analyses between PD-1 rs7421861 A>G polymorphism and EGJA risk by sex, age, smoking status and alcohol consumption.

Variable PD-1 rs7421861 A>G (case/control)a Adjusted OR b (95% CI); P
AA AG GG AA AG GG AG/GG GG vs. (AG/AA)
Sex
Male 455/819 262/331 29/41 1.00 1.40 (1.15–1.70); P: 0.001 1.20 (0.74–1.97); P: 0.462 1.41 (1.16–1.71); P: 0.001 1.10 (0.67–1.79); P: 0.712
Female 187/347 96/123 12/13 1.00 1.37 (0.99–1.89); P: 0.058 1.65 (0.73–3.69); P: 0.228 1.46 (1.07–2.00); P: 0.017 1.55(0.69–3.46); P: 0.286
Age
<64 286/590 173/212 23/21 1.00 1.62 (1.27–2.08); P: < 0.001 2.07 (1.12–3.83); P: 0.021 1.73 (1.36–2.20); P: < 0.001 1.82 (0.99–3.35); P: 0.054
≥64 356/576 185/242 18/33 1.00 1.21 (0.96–1.53); P: 0.108 0.87 (0.48–1.56); P: 0.633 1.20 (0.96–1.50); P: 0.113 0.83 (0.46–1.49); P: 0.531
Smoking status
Never 465/925 263/353 26/43 1.00 1.42 (1.17–1.73); P: < 0.001 1.16 (0.70–1.92); P: 0.558 1.45 (1.20–1.75); P: < 0.001 1.07 (0.65–1.75); P: 0.804
Ever 177/241 95/101 15/11 1.00 1.29 (0.91–1.82); P: 0.149 1.85 (0.82–4.17); P: 0.139 1.36 (0.98–1.90); P: 0.068 1.72 (0.77–3.85); P: 0.188
Alcohol consumption
Never 544/1050 311/408 32/47 1.00 1.42 (1.19–1.70); P: < 0.001 1.26 (0.80–2.00); P: 0.326 1.46 (1.22–1.73); P: < 0.001 1.15 (0.73–1.82); P: 0.541
Ever 98/116 47/46 9/7 1.00 1.14 (0.69–1.89); P: 0.609 1.73 (0.59–5.09); P: 0.322 1.21 (0.75–1.95); P: 0.441 1.66 (0.57–4.83); P: 0.356

a The genotyping was successful in 1063 (97.93%) EGJA cases, and 1677 (99.82%) controls for PD-1 rs7421861 A>G;

b Adjusted for age, sex, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.